Dr Lalchandani Labs Limited

Equities

DLCL6

INE871Z01013

Healthcare Facilities & Services

Market Closed - Bombay S.E. Other stock markets 03:30:51 29/05/2024 pm IST			5-day change	1st Jan Change
22.93 ^INR	+4.99%		+5.81%	+8.01%

02/05	Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer	CI
06/04	Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer	CI

Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2021

July 12, 2021 at 07:11 pm IST

Dr Lalchandani Labs Limited announced earnings results for the full year ended March 31, 2021. For the full year, the company announced total revenue was INR 97.8 million compared to INR 61.039 million a year ago. Net income was INR 10.113 million compared to INR 4.743 million a year ago. Basic earnings per share from continuing operations was INR 2.33 compared to INR 1.09 a year ago.

Latest news about Dr Lalchandani Labs Limited

Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer	02/05	CI
Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer	06/04	CI
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer	03/02	CI
Dr Lalchandani Labs Limited Approves Resignation of Monika Joshi as Company Secretary and Compliance Officer	27/11	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2023	14/11	CI
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary	23/23/23	CI
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023	25/23/25	CI
Dr Lalchandani Labs Limited Announces Resignation of Archana R Jha as Company Secretary	19/23/19	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	19/23/19	CI
Dr Lalchandani Labs Limited Announces Management Changes	16/23/16	CI
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer	05/23/05	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2022	14/22/14	CI
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer	09/22/09	CI
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh	30/22/30	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
Dr Lalchandani Labs to Provide Diagnostic Services in Delhi, India, as Part of New Deal	21/22/21	MT
Dr Lalchandani Labs Limited Appoints Swati Chandra as Additional Director	09/22/09	CI
Dr Lalchandani Labs Limited Announces Resignation of Ms. Manica Gupta as Non-Executive Director	15/21/15	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2021	12/21/12	CI
Dr Lalchandani Labs' : Net Profit Soars in Fiscal Q4	13/21/13	MT
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2021	12/21/12	CI
880,000 Equity Shares of Dr Lalchandani Labs Limited are subject to a Lock-Up Agreement Ending on 9-MAY-2021.	09/21/09	CI
Dr Lalchandani Labs : Gets Approval to be Listed as COVID-19 Vaccination Center	09/21/09	MT
Dr Lalchandani Labs Limited Announces Unaudited Earnings Results for the Half Year Ended September 30, 2020	13/20/13	CI
Dr Lalchandani Labs Limited Announces Increase in Capacity for Covid-19 RT-PCR Testing	28/20/28	CI

Chart Dr Lalchandani Labs Limited

Duration

Period

More charts

Company Profile

Dr Lalchandani Labs Limited is an India-based company, which is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. Through its integrated network, the Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The Company has its own blood banking services through its sister concern CPC blood bank. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Sector

Healthcare Facilities & Services

Calendar

30/05/2024 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
DR LALCHANDANI LABS LIMITED	+8.01%	1.14M
SONIC HEALTHCARE LIMITED	-24.88%	7.74B
RADNET, INC.	+70.87%	4.39B
DR. LAL PATHLABS LIMITED	+2.96%	2.61B
SYNLAB AG	-7.01%	2.53B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.62%	2.22B
NEOGENOMICS, INC.	-12.67%	1.8B
FLEURY S.A.	-19.62%	1.54B
METROPOLIS HEALTHCARE LIMITED	+18.85%	1.23B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.60%	1.15B

Medical & Diagnostic Laboratories